U.S. Drug Administration Approves Doctors Use Virus Recovery Plasma Plants to Treat Patients • President Trump Welcomes Announcement at Press Release
Corona test in Finland
Photo:
Reuters
In line for patients? The US Food and Drug Administration (FDA) has approved doctors (Monday) to use blood plasma doses from corona patients who have developed antibodies to the virus in patients.
The FDA announcement was accompanied by a press conference hosted by US President Donald Trump, who welcomed the approval and defined the move as a significant step in the fight against Corona. According to preliminary FDA trials, the use of plasma can save about a third of the patients who receive the treatment. However, this is at this stage an emergency certificate issued by the administration and the results of the study will be examined with increasing plasma treatment.
"We have been waiting for this for a long time," Trump said of the FDA announcement, "I am pleased to announce the historic development in the fight against the Chinese virus - a development that will save many lives," he added. The drug director's announcement came a day after the president attacked director and head of staff Stephen Hahn on Twitter, claiming that the organization and Hahn were making it difficult to deal with the plague, and even linked the obstacles the FDA put in its way to handling the upcoming US election.
